Federation Des Caisses Desjardins Du Quebec Essa Pharma Inc. Transaction History
Federation Des Caisses Desjardins Du Quebec
- $18.9 Billion
- Q3 2024
A detailed history of Federation Des Caisses Desjardins Du Quebec transactions in Essa Pharma Inc. stock. As of the latest transaction made, Federation Des Caisses Desjardins Du Quebec holds 4,050 shares of EPIX stock, worth $7,128. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,050
Previous 2,050
97.56%
Holding current value
$7,128
Previous $10,000
140.0%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding EPIX
# of Institutions
34Shares Held
35.1MCall Options Held
15.8KPut Options Held
21K-
Bvf Inc San Francisco, CA8.75MShares$15.4 Million1.69% of portfolio
-
Bellevue Group Ag Kuesnacht, V87.88MShares$13.9 Million0.8% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT4.29MShares$7.55 Million2.21% of portfolio
-
Morgan Stanley New York, NY4.18MShares$7.36 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY3.26MShares$5.74 Million0.32% of portfolio
About ESSA Pharma Inc.
- Ticker EPIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 44,073,100
- Market Cap $77.6M
- Description
- ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses on developing novel and proprietary therapies for the treatment of prostate cancer. It develops EPI-7386, an oral candidate that is in a Phase I clinical study for the treatment of patients with metastatic castration-resistant prostate cancer. The company has collaboration agreem...